As aberrant epigenetic regulation was also demonstrated in BC, several clinical studies investigated the efficacy of DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors used as monotherapies, showing their limited antitumor efficacy at the maximum tolerated doses (Buocikova et al., 2020). The gene discussed is DNMT1; the disease is breast cancer.